Chromatography
Nitrosamines remain a critical concern across multiple industries, from pharmaceuticals to cosmetics, due to their potential carcinogenic risks. Regulatory bodies such as the FDA and EMA have established stringent thresholds, compelling manufacturers to implement advanced monitoring and detection strategies to ensure compliance.
One of the greatest challenges in nitrosamine analysis is detecting a nitrosamine that was not anticipated in a sample. While targeted testing via GC or LC can identify known nitrosamines - provided reference standards are available - unexpected nitrosamine contamination may go undetected.
Ellutia’s recent webinar explored innovative analytical approaches that enable the identification of potential nitrosamine contaminants without requiring specific reference standards.
The webinar also featured a live Q&A session with Ellutia’s Senior Application Chemist, Mr Jonathan Angove, addressing audience questions in real time.
If you missed the live session, you can watch the full recording here.
For further details about the ATNA and how it can enhance your nitrosamine analysis, visit Ellutia’s website.
More information online
ILM 51.5 July 2026